Evidence map›Paper›PMID 32658456›Full record

ArticleACS nano2020

Splenic Capture and

Leon Newman, Dhifaf A Jasim, Eric Prestat, Neus Lozano, Irene de Lazaro, Yein Nam, Bakri M Assas, Joanne Pennock, Sarah J Haigh, Cyrill Bussy and 1 more

Open access · hybridAbstract read
In one paragraph

Article in ACS nano, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Safety Assessment of Graphene-Based Materials.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Leon NewmanNanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, M13 9PT, United Kingdom.
Dhifaf A JasimNanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, M13 9PT, United Kingdom.
Eric PrestatDepartment of Materials, School of Natural Sciences, The University of Manchester, Manchester, M13 9PL, United Kingdom.
Neus LozanoNanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, M13 9PT, United Kingdom.
Irene de LazaroNanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, M13 9PT, United Kingdom.ORCID 0000-0002-2775-0173
Yein NamNanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, M13 9PT, United Kingdom.
Bakri M AssasLydia Becker Institute of Immunology and Inflammation, and Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PT, United Kingdom.
Joanne PennockLydia Becker Institute of Immunology and Inflammation, and Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PT, United Kingdom.
Sarah J HaighDepartment of Materials, School of Natural Sciences, The University of Manchester, Manchester, M13 9PL, United Kingdom.ORCID 0000-0001-5509-6706
Cyrill BussyNanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, M13 9PT, United Kingdom.ORCID 0000-0001-8870-443X
Kostas KostarelosNanomedicine Lab, National Graphene Institute and Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, M13 9PT, United Kingdom.ORCID 0000-0002-2224-6672
University of Manchester · GBKing Abdulaziz University · SA

Funding

Wellcome Trust
6 · The paper itself

Abstract

Carbon nanomaterials, including 2D graphene-based materials, have shown promising applicability to drug delivery, tissue engineering, diagnostics, and various other biomedical areas. However, to exploit the benefits of these materials in some of the areas mentioned, it is necessary to understand their possible toxicological implications and long-term fate

Indexed as

GraphiteNanostructuresAnimalsSpleenTissue Distributiongraphene oxideGraphite2D materialsdegradationmacrophagenanomedicinetoxicology

Identifiers

PMID32658456
PMCPMC7458483
OpenAlexW3042048921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.